MedTrace Logo

Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

NCT00444717 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-07-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.

Conditions

Interventions

DRUG

pitavastatin

Pitavastatin (2mg/day) was administered for 12 weeks

Sponsors & Collaborators

  • Aichi Gakuin University

    lead OTHER

Principal Investigators

  • Tatsuaki Matsubara, MD, PhD · Department of Internal Medicine, School of Dentistry, Aichi Gakuin University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00444717 on ClinicalTrials.gov